Through autocrine mechanisms, CXCL10–CXCR3 signaling supports OS cell proliferation, survival, and motility, enabling tumor adaptation to the harsh, often hypoxic and nutrient-deprived TME. The gene discussed is CXCR3; the disease is neoplasm.